Skip to main content
All lobbying filings

CVS HEALTH (AND SUBSIDIARIES)

Lobbying for CVS HEALTH (AND SUBSIDIARIES) · Health Care

 Filing 3rd Quarter - Report
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $2,150,000.00 expenses · posted Oct 20, 2025

Official filing document

 Bills named in this filing 17
 Lobbying activity 7
Pharmacy

Issues related to retail pharmacy, drug pricing, and women's health. H.R. 3164 - The Ensuring Community Access to Pharmacist Services Act of 2025 S. 2426 - The Equitable Community Access to Pharmacist Services Act P.L. 119-21 - The One Big, Beautiful Bill Act - issues related to retail pharmacy

Taxation/Internal Revenue Code

Issues related to corporate tax. P.L. 119-21 - The One Big, Beautiful Bill Act H.R. 3010/S. 1785 - No Handouts for Drug Advertisement Act

Medicare/Medicaid

Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to pharmacy testing, vaccination, and treatment. Issues related to Accountable Care Organizations. Issues related to Medicare Shared Savings Program. Issues related to Medicaid. S. 882, The Patients Before Middlemen (PBM) Act S. 927, The Protecting Pharmacies in Medicaid Act S. 1105 - No Unreasonable Payments, Coding, Or Diagnoses for the Elderly Act P.L. 119-21 - The One Big, Beautiful Bill Act - - issues related to Medicaid and PBMs H.R. 4317, The Pharmacy Benefit Manager (PBM) Reform Act

Insurance

Issues related to employer, small group and individual insurance markets. H.R. 2214, the Delinking Revenue from Unfair Gouging (DRUG) Act P.L. 119-21 - The One Big, Beautiful Bill Act H.R. 5433 - The Patients Over Profits Act S. 2836 - The Patients Over Profits Act H.R. 4409 - The Fair Pharmacies for Federal Employees Act of 2025

Labor Issues/Antitrust/Workplace

Issues related to the competitive nature of the pharmacy benefit manager industry and workforce issues. P.L. 119-21, The One Big, Beautiful Bill Act S. 2099, The Restore Prescription Drugs Discount Act

Consumer Issues/Safety/Products

Issues related to organized retail crime. H.R. 2853/S. 1404, The Combatting Organized Retail Crime Act

Advertising

S. 2068 - The End Prescription Drugs Ads Now Act H.R. 3789 - The Drug-price Transparency for Consumers Act of 2025

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem